Prag Bosimi Synthetics Intrinsic Value
Prag Bosimi Synthetics (PRAGBOS) median intrinsic value is ₹1.00 from 3 valuation models (range ₹1–₹3), vs current price ₹1.88 — -46.8% downside (Trading Above Calculated Value), margin of safety -88.0%. Read Prag Bosimi Synthetics dividend payments for the complete payout history and dividend yield track record.
PRAGBOS Valuation Methods Summary — DCF, Graham Number & P/E
Prag Bosimi Synthetics intrinsic value across 3 models vs current price ₹1.88 — upside/downside and value range per method. For current market price and key ratios, visit Prag Bosimi Synthetics share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹0.56 | ₹0.50 - ₹0.62 | -70.2% | Revenue/Share: ₹0.43, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹2.58 | ₹2.32 - ₹2.84 | +37.2% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1.00 | ₹0.80 - ₹1.20 | -46.8% | CF Growth: 5.0%, Discount: 15% |
PRAGBOS Intrinsic Value vs Market Price — All Valuation Models
Prag Bosimi Synthetics fair value range ₹1–₹3 vs current market price ₹1.88 across 3 valuation models. Analyse Prag Bosimi Synthetics ownership pattern to track promoter, FII and institutional holdings.
PRAGBOS Intrinsic Value Analysis — Undervalued or Overvalued?
Prag Bosimi Synthetics median intrinsic value ₹1.00, current price ₹1.88 — Trading Above Calculated Value by 46.8%, margin of safety -88.0%.
What is the intrinsic value of PRAGBOS?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Prag Bosimi Synthetics (PRAGBOS) is ₹1.00 (median value). With the current market price of ₹1.88, this represents a -46.8% variance from our estimated fair value.
The valuation range spans from ₹0.56 to ₹2.58, indicating ₹0.56 - ₹2.58.
Is PRAGBOS undervalued or overvalued?
Based on our multi-method analysis, Prag Bosimi Synthetics (PRAGBOS) appears to be trading above calculated value by approximately 46.8%.
PRAGBOS Financial Health — Key Ratios vs Industry Benchmarks
Prag Bosimi Synthetics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.02 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 106.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 170.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.02x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
PRAGBOS Cash Flow Quality — Operating & Free Cash Flow
Prag Bosimi Synthetics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹0 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |